AnaptysBio, Inc. (ANAB)
63.15
+0.96
(+1.54%)
USD |
NASDAQ |
May 15, 16:00
63.22
+0.07
(+0.11%)
After-Hours: 20:00
AnaptysBio Shareholders Equity (Quarterly) : 12.75M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 280.76M |
| TG Therapeutics, Inc. | 583.13M |
| ADMA Biologics, Inc. | 390.32M |
| Mirum Pharmaceuticals, Inc. | 242.49M |
| Rocket Pharmaceuticals, Inc. | 238.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 329.68M |
| Total Liabilities (Quarterly) | 316.94M |
| Debt to Equity Ratio | 21.76 |
| Current Ratio | 7.580 |
| Net Debt Paydown Yield | 1.72% |